DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,418 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $907,829 | -0.5% | 3,633 | -0.5% | 0.04% | -2.2% |
Q1 2024 | $912,351 | -8.1% | 3,653 | -14.9% | 0.04% | -18.2% |
Q4 2023 | $993,142 | -7.1% | 4,293 | -0.4% | 0.06% | -20.3% |
Q3 2023 | $1,069,062 | -12.8% | 4,309 | -15.6% | 0.07% | -1.4% |
Q2 2023 | $1,225,559 | +37.0% | 5,106 | +43.9% | 0.07% | +27.3% |
Q1 2023 | $894,615 | -4.9% | 3,549 | +0.1% | 0.06% | -16.7% |
Q4 2022 | $941,046 | +1.1% | 3,545 | -1.6% | 0.07% | -14.3% |
Q3 2022 | $931,000 | 0.0% | 3,603 | -1.9% | 0.08% | -3.8% |
Q2 2022 | $931,000 | -10.5% | 3,672 | +3.5% | 0.08% | +12.7% |
Q1 2022 | $1,040,000 | -14.2% | 3,547 | -3.7% | 0.07% | -17.4% |
Q4 2021 | $1,212,000 | +6.6% | 3,683 | -1.4% | 0.09% | -4.4% |
Q3 2021 | $1,137,000 | +8.9% | 3,734 | -4.0% | 0.09% | +8.4% |
Q2 2021 | $1,044,000 | -24.3% | 3,889 | -36.5% | 0.08% | -27.8% |
Q1 2021 | $1,379,000 | +2.1% | 6,126 | +0.7% | 0.12% | +0.9% |
Q4 2020 | $1,351,000 | +3.8% | 6,084 | +0.7% | 0.11% | -12.3% |
Q3 2020 | $1,301,000 | +90.2% | 6,042 | +56.1% | 0.13% | +80.6% |
Q2 2020 | $684,000 | +17.5% | 3,871 | -7.9% | 0.07% | +4.3% |
Q1 2020 | $582,000 | -2.3% | 4,203 | +8.2% | 0.07% | +19.0% |
Q4 2019 | $596,000 | +6.2% | 3,883 | -0.1% | 0.06% | +1.8% |
Q3 2019 | $561,000 | -21.9% | 3,887 | -22.7% | 0.06% | -17.4% |
Q2 2019 | $718,000 | +34.0% | 5,026 | +23.8% | 0.07% | +30.2% |
Q1 2019 | $536,000 | +9.8% | 4,059 | -14.3% | 0.05% | 0.0% |
Q4 2018 | $488,000 | – | 4,734 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |